Does high SHBG lower free (bioavailable) testosterone?

Sex hormone-binding globulin (SHBG) is the primary glycoprotein responsible for transporting and regulating the bioavailability of sex steroids in human circulation. In both pre- and postmenopausal women, SHBG serves as the gatekeeper for testosterone action, directly controlling the equilibrium between bound and biologically active hormone fractions.

Clinical and Physiological Impact

The relationship between SHBG and testosterone is defined by a high-affinity binding interaction that dictates hormone distribution.

• Sequestration mechanism: SHBG binds testosterone with significantly higher affinity than other transport proteins like albumin. As SHBG concentrations increase, a larger percentage of total testosterone is sequestered within these protein complexes.
• Free Testosterone Index (FTI): Clinical data in women show that even when total testosterone levels remain constant, elevated SHBG levels lead to a measurable decrease in free testosterone. Studies indicate that SHBG is the strongest predictor of free androgen levels, with an inverse correlation that is critical for assessing androgenic status in women aged 50 and older.
• Bioavailability: According to the "free hormone hypothesis," only the unbound (free) testosterone or the weakly bound (albumin-bound) fraction can easily cross cell membranes to bind to androgen receptors. Therefore, high SHBG levels effectively lower the "bioavailable" pool available to target tissues.

Mechanistic Explanation

The molecular behavior of SHBG is central to its role in regulating testosterone activity.

• Molecular Structure: SHBG exists as a homodimer consisting of two identical subunits. Each dimer contains a specific steroid-binding pocket located in the amino-terminal laminin G-like domain.
• Binding Dynamics: Testosterone binds to SHBG at a 1:1 molar ratio per subunit. The binding is reversible but highly stable (Ka ≈ 10⁹ M⁻¹). This high affinity ensures that under normal physiological conditions, approximately 60–70% of circulating testosterone is bound to SHBG, 30–40% to albumin, and only 1–2% remains free.
• Regulatory Loop: In women around age 50, changes in insulin sensitivity, thyroid function, and estrogen levels can significantly alter SHBG production in the liver. An increase in SHBG shifts the hormonal equilibrium, drawing more testosterone into the bound state and reducing the concentration of free molecules that can interact with receptors in muscle, bone, and brain tissues.

Bottom line

High SHBG levels directly lower free (bioavailable) testosterone by sequestering the hormone in high-affinity binding complexes. For a 50-year-old woman, elevated SHBG can result in low bioavailable testosterone even if total testosterone levels appear normal, as the protein effectively prevents the hormone from reaching target tissues.